Ultrasonic Surgical Aspirator Research Articles

Current status and future perspectives of robotic liver surgery.

Robotic liver resection has been reported in case series since the early 2000s. The surgical robot is capable of precise operation using articulated forceps with seven degrees of freedom. The robot also eliminates tremors and provides a good surgical field with highly detailed 3D high-definition images. The clinical results demonstrating their usefulness have been increasing year by year. Initially, a shorter hospital stay was observed in comparison with open hepatectomy. Recent reports have also shown lower conversion and complication rates in comparison with laparoscopic hepatectomy. The clamp and crush method with bipolar forceps, sealing devices, ultrasonic shears, and the combined procedure of Cavitron ultrasonic surgical aspirator and robotic forceps as hybrid procedures have been reported as effective methods of parenchymal transection in robotic surgery. Theoretically, the advantages of the robotic platform allow for more complex liver resection around hilar structures and major blood vessels, as well as for vascular reconstruction or biliary reconstruction. The application of robotic liver surgery for hilar cholangiocarcinoma, living donor hepatectomy, and living donor liver transplantation has been reported. Robotic liver surgery is becoming more popular for certain indications; however, it is important to further evaluate its long-term surgical and oncological outcomes and costs in comparison with conventional laparoscopic and open liver surgery, based on accumulated experience.

Cavitron ultrasonic surgical aspirator (CUSA) compared with conventional pancreatic transection in distal pancreatectomy: study protocol for the randomised controlled CUSA-1 pilot trial

BackgroundPostoperative pancreatic fistula (POPF) remains the most common and serious complication after distal pancreatectomy. Many attempts at lowering fistula rates have led to unrewarding insignificant results as still up to...

Safety and Feasibility of Laparoscopic Liver Resection with the Clamp-Crush Method Using the BiSect.

Various energy devices are available for resection of the liver parenchyma during laparoscopic liver resection (LLR). We have historically performed liver resections using the Cavitron Ultrasonic Surgical Aspirator (CUSA). More recently, we have used new bipolar forceps (BiSect; Erbe Elektromedizin GmbH, Tübingen, Germany) to perform clamp-crush dissection with good results. The BiSect is a reusable bipolar forceps with a laparoscopic dissecting forceps tip and both an incision mode and coagulation mode. We evaluated the perioperative clinical course of patients who underwent LLR using the clamp-crush method with the BiSect compared with the CUSA. This single-center case control study involved patients with liver metastasis from colorectal cancer who underwent LLR using either the BiSect or CUSA at our hospital from January 2019 to December 2022. We performed the LLR using CUSA from January 2019 to early October 2020. After introduction of the BiSect in late October 2020, we used BiSect for the LLR. Before surgery, the three-dimensional liver was constructed based on computed tomography images, and a preoperative simulation was performed. We evaluated the results of LLR using the BiSect versus the CUSA and assessed the short-term results of LLR. During the study period, we performed partial liver resection using the BiSect in 26 patients and the CUSA in 16 patients. In the BiSect group, the median bleeding volume was 55 mL, the median operation time was 227 minutes, and the median postoperative length of hospital stay was 9 days. In the CUSA group, the median bleeding volume was 87 mL, the median operation time was 305 minutes, and the median postoperative length of hospital stay was 10 days. There were no statistically significant differences in the clinical course including bile leakage, bile duct stenosis, and post operative hospital stay between the two groups. Compared with LLR using the CUSA, the clamp-crush method using the BiSect in LLR is a safe and useful liver transection technique. Further study should be conducted to clarify whether BiSect is safe and useful in LLR for patients with other tumor types and patients who undergo other procedures.

A Multicenter, Open-Label, Single-Arm Phase I Trial of Dual-Wield Parenchymal Transection: A New Technique of Liver Resection Using the Cavitron Ultrasonic Surgical Aspirator and Water-Jet Scalpel Simultaneously (HiSCO-14 Trial).

This study evaluated the safety and feasibility of a technique of liver resection named dual-wield parenchymal transection technique (DWT), using cavitron ultrasonic surgical aspirator (CUSA) and water-jet scalpel simultaneously. This multicenter, prospective, open-label, and single-arm phase I trial included patients aged 20 years or older with hepatic tumors indicated for surgical resection and scheduled for open radical resection. This study was conducted at two institutions affiliated with the Hiroshima Surgical Study Group of Clinical Oncology (HiSCO). The primary endpoint was the proportion of massive intraoperative blood loss (≥ 1000 mL). The secondary endpoints were the amount of blood loss, operative time, parenchymal transection speed, postoperative complications, and mortality. The safety endpoints were device failure and adverse events associated with devices. From June 2022 to May 2023, 20 patients were enrolled; one was excluded and 19 were included in the full analysis set (FAS). In the FAS, segmentectomy was performed in nine cases, sectionectomy in four cases, and hemihepatectomy in six cases. Radical resection was achieved in all patients. Intraoperative blood loss greater than 1000 mL was observed in five patients (26.3%). The median amount of blood loss was 545 mL (range, 180-4413), and blood transfusions were performed on two patients (10.5%). The median operative time was 346 minutes (range, 238-543) and the median parenchymal transection speed was 1.2 cm2/minute (range, 0.5-5.1). Postoperative complications of Clavien-Dindo classification ≥ Grade 3 occurred in four patients (21.1%). No mortalities occurred in this study. In the safety analysis, there were no device failures or adverse events associated with devices. This study demonstrated the safety and feasibility of DWT for liver resection. The efficacy of the DWT will be evaluated in future clinical trials.

IMMU-46. MONITORING T-CELL DYNAMICS AND CHECKPOINT EXPRESSION IN THE IMMUNE MICROENVIRONMENT OF PEDIATRIC HIGH GRADE BRAIN TUMORS: THE MIMIC PROGRAM

Abstract BACKGROUND Pediatric high grade brain tumors (pHGBT) pose a significant challenge due to limited treatment options and poor prognosis. Understanding the immune landscape, in particular T cell profiles and functionality, is of high interest as numerous immunotherapeutic approaches focus on or utilize T-cells. This study aimed to characterize T-cell phenotypes and their potential for immunotherapeutic interventions in tumor fragments (obtained from cavitron ultrasonic surgical aspiration (CUSA)) and tumor tissue (biopsy), in comparison with peripheral blood, collected from pHGBT patients. METHODS Spectral flow cytometry was employed to characterize the presence of T-cell subsets and their functional phenotype. RESULTS T cells were detected in all materials with similar CD8/CD4 ratios. At diagnosis, T-cells in the tumor microenvironment exhibited significantly increased expression of PD1, LAG3 and TIM3 checkpoint receptors compared to peripheral blood. This difference was more pronounced in biopsy samples compared to CUSA fragments. T-cell composition and phenotype in peripheral blood were similar to healthy adult controls at diagnosis. However, during therapy, the T-cell compartment showed a shift towards a higher CD8/CD4 ratio, accompanied by increased activation markers (CD25, CD69) and checkpoint receptor expression . Notably, CD8+ T-cells in both peripheral blood and tumor microenvironment showed high production of Granzyme B. CONCLUSION Our findings demonstrate that despite the high expression of checkpoint receptors on CD8+ T-cells, these cells retain the capability to produce significant amounts of Granzyme B, indicating their potential for cytotoxic activity. Furthermore, variations in checkpoint receptor expression on T-cells were observed when comparing CUSA fragments to biopsy material. Functional assays will further validate these findings and elucidate the functional status of these cells. Understanding the function of T-cells within the tumor microenvironment is essential for designing novel combination therapies to enhance T-cell cytotoxicity against pHGBT.

IMMU-58. CHARACTERIZATION OF MYELOID CELL POPULATIONS IN PEDIATRIC HIGH-GRADE BRAIN TUMORS: THE MIMIC PROGRAM

Abstract BACKGROUND Pediatric high-grade brain tumors (pHGBT) pose treatment challenges with limited options. Myeloid cells, particularly tumor-associated macrophages (TAMs) in the tumor-microenvironment (TME), exhibit potent immunosuppressive features inhibiting effective anti-tumor T-cell responses. Targeting these cells holds promise to improve outcomes, however the underlying mechanisms of myeloid cell dysfunction remain poorly understood. This study aimed to comprehensively characterize myeloid cell populations in pHGBT and investigate their functional phenotype. METHODS Spectral flow cytometry was performed on tumor tissue (biopsies or resections) and tumor fragments obtained by cavitron ultrasonic surgical aspiration (CUSA) in pHGBT patients (High-grade glioma n=2, Ependymoma n=1, Medulloblastoma n=6, Pilocytic Astrocytoma n=2) enrolled in the MIMIC program. This allowed quantification and comprehensive characterization of myeloid cell populations within the TME. RESULTS The pHGBT TME showed a low abundance of immune cells across different entities, with myeloid cells comprising the predominant proportion. CD49d was used to identify invading cells derived from bone marrow (CD49+) and resident microglia (CD49-). The total TAMs/microglia population was detected in both tumor tissue and CUSA tumor fragments in similar proportions, however resident CD49d- microglia were notably increased in CUSA tumor fragments. Additionally, invading TAMs displayed a mixed "M1" and "M2" polarization phenotype and exhibited higher expression of the chemokine receptor CCR2 and HLA-DR, and of the immune-checkpoint receptors SIRP1A/B, CD33, and TIM3, compared to resident microglia. CONCLUSIONS TAMs play a multifaceted role in pHGBT. The high expression of immune-checkpoint receptors by invading TAMs suggests an immunosuppressive phenotype, potentially facilitating tumor growth, infiltration and (immune)therapy escape. Although, differences between disease entities could not yet be analyzed, disparities were observed in the TME between tumor and CUSA samples, likely related to spatial cellular organization. Understanding TAM dynamics and functional differences between invading and resident subsets, as well as their underlying mechanisms, is crucial for advancing therapeutic efficacy in pHGBT.

Techniques of Laparoscopic Right Posterior Sectionectomy: Glissonian Approach and a Parenchymal Transection Technique.

Laparoscopic liver resections (LLR) have been widely accepted as a treatment option for liver tumors. They offer several advantages over open liver resections, including less blood loss, reduced wound pain, and shorter hospital stays with a comparable oncological outcome. However, laparoscopic resection of lesions in the right posterior section of the liver is challenging due to difficulties in bleeding control and visualizing the surgical field. In the past, laparoscopic right posterior sectionectomy (LRPS) was still in the exploration phase, with undefined risks in the Second International Consensus Conference on LLR in 2014. However, recent technological advancements and increased surgical experience have shown that LRPS can be safe and feasible. It has been found to reduce hospital stay and blood loss compared to open surgery. This manuscript aims to provide a detailed description of the steps involved in LRPS. The key factors contributing to our success in this challenging procedure include proper liver retraction and exposure, the use of an intrahepatic Glissonian approach for inflow control, a technique called the 'ultrasonic scalpel mimic Cavitron ultrasonic surgical aspirator (CUSA)' for parenchymal transection, early identification of the right hepatic vein, and meticulous bleeding control using bipolar diathermy.

Establishment of vestibular schwannoma primary cell cultures obtained from cavitron ultrasonic surgical aspirator tissue material

BackgroundVestibular schwannoma (VS) is a benign tumor arising from the Schwann cells of the eighth cranial nerve. The complexity in treatment is associated with unpredictable progression of this tumor. Some of the VS do not alter for years, while others rapidly increase in size. The mechanisms behind size progression are not well studied. Furthermore, despite several studies, there is no pharmacological treatment available for sporadic VS. Therefore, in vitro models are essential tools to study the cellular and molecular processes of VS. In addition, patient-derived cell cultures are important for substance screening to investigate pharmacological approaches in vitro. New methodThis study presents a simple and fast method for culturing VS cells from patient tissue material obtained using a cavitron ultrasonic surgical aspirator (CUSA). In addition, the cells were characterized based on the expression of schwannoma markers, growth properties and screened for fibroblast contamination. ResultWe could show that CUSA obtained material is a suitable resource for isolation of VS primary cultures and enables real time analysis on living cells. Comparison with Existing MethodsTo date, only a few protocols are available for culturing VS cells from patient tissue material. A disadvantage of these methods is the relatively large amount of tissue needed to obtain the primary cells, which can be difficult, especially in small VS. By obtaining the cells from the CUSA, there is the possibility to establish a primary culture even with limited material. ConclusionThis approach could be particularly useful for testing substances that represent candidates for drug therapy of vestibular schwannoma.

Cavitron Ultrasonic Surgical Aspirator Makes it Easier for Neurosurgeons. What About Pathologists?

Cavitron Ultrasonic Surgical Aspirator Makes it Easier for Neurosurgeons. What About Pathologists?

Reduction of Blood Loss by Means of the Cavitron Ultrasonic Surgical Aspirator for Thoracoscopic Salvage Anatomic Lung Resections.

In centrally located lung tumors, salvage pulmonary resections pose challenges due to adhesions between the pulmonary parenchyma, chest wall, and hilum. This study aimed to investigate the surgical outcomes associated with Cavitron Ultrasonic Surgical Aspirator (CUSA) usage in thoracoscopic salvage pulmonary resections. Patients with centrally located advanced-stage lung tumors who underwent salvage anatomic resections following systemic or radiotherapy were included. They were categorized into CUSA and non-CUSA groups, and perioperative parameters and surgical outcomes were analyzed. Results: The study included 7 patients in the CUSA group and 15 in the non-CUSA group. Despite a longer median surgical time in the CUSA group (3.8 h vs. 6.0 h, p = 0.021), there was a significant reduction in blood loss (100 mL vs. 250 mL, p = 0.014). Multivariate analyses revealed that the use of CUSA and radiotherapy had opposing effects on blood loss (β: -296.7, 95% CI: -24.8 to -568.6, p = 0.034 and β: 282.9, 95% CI: 19.7 to 546.3, p = 0.037, respectively). In conclusion, while using CUSA in the salvage anatomic resection of centrally located lung cancer may result in a longer surgical time, it is crucial in minimizing blood loss during the procedure.

Modified Laparoscopic Anatomic Hepatectomy: Two-Surgeon Technique Combined with the Simple Extracorporeal Pringle Maneuver

Laparoscopic anatomic hepatectomy (LAH) has become increasingly prevalent worldwide in recent years. However, LAH remains a challenging procedure due to the anatomical characteristics of the liver, with intraoperative hemorrhage being a primary concern. Intraoperative blood loss is the leading cause of conversion to open surgery; therefore, effective management of bleeding and hemostasis is crucial for a successful LAH. The two-surgeon technique is proposed as an alternative to the traditional single-surgeon approach, with potential benefits in reducing intraoperative bleeding during laparoscopic hepatectomy. However, there remains a lack of evidence to determine which mode of the two-surgeon technique yields superior patient outcomes. Besides, to our knowledge, the LAH technique, which involves the use of a cavitron ultrasonic surgical aspirator (CUSA) by the primary surgeon while an ultrasonic dissector by the second surgeon, has been rarely reported before. Herein, we present a modified, two-surgeon LAH technique, wherein one surgeon employs a CUSA while the other uses an ultrasonic dissector. This technique is combined with a simple extracorporeal Pringle maneuver and low central venous pressure (CVP) approach. In this modified technique, the primary and secondary surgeons utilize a laparoscopic CUSA and an ultrasonic dissectorconcurrently to achieve precise and expeditious hepatectomy. A simple extracorporeal Pringle maneuver, combined with the maintenance of low CVP, is employed to regulate the hepatic inflow and outflow in order to minimize intraoperative bleeding. This approach facilitates the attainment of a dry and clean operative field, which allows for the precise ligation and dissection of blood vessels and bile ducts. The modified LAH procedure is simpler and safer due to its effective control over bleeding as well as the seamless transition between the roles of primary and secondary surgeons. It holds great promise for future clinical applications.

Comments on Experience With Establishing a Robotic Donor Hepatectomy Program for Pediatric Liver Transplantation.

Comments on Experience With Establishing a Robotic Donor Hepatectomy Program for Pediatric Liver Transplantation.

Surgical removal of an orbital liposarcoma in a dog using the cavitron ultrasonic surgical aspirator

AbstractA 9‐year‐old boxer presented with unilateral exophthalmos, reduced globe retropulsion and central exposure keratitis in the right eye. On the superolateral orbital quadrant, a firm, well‐limited mass in close proximity to the globe was detected. Ultrasonic and computed tomography examinations confirmed a retrobulbar mass. The biopsy examination revealed the presence of a tumour of adipocytes, consistent with hibernoma. The retrobulbar mass was surgically removed using dorsal orbitotomy with a cavitron ultrasonic surgical aspirator. Complete retrobulbar mass removal was achieved with minimal and transient postoperative complications. The histopathological examination of the mass fragment obtained during surgery showed liposarcoma. Controlled computed tomography performed 4 months after surgery did not reveal signs of recurrence or metastasis. Ophthalmic examination was within normal limits during 1 year of follow‐up. The cavitation ultrasonic surgical aspirator allows precise mass excision with preservation of delicate orbital structures and is particularly useful in cases with challenging anatomical access.

Overview of the Use of CUSA as a Novel Technique to Aid in Annular Decalcification

Mitral annular calcification (MAC) is a major complicating factor in cardiac valve surgery, leading to increased difficulty and complexity in valve replacement. Utilisation of the Cavitron Ultrasonic Surgical Aspirator (CUSA) for annular decalcification has facilitated successful surgical intervention in the setting of severe calcific valve disease in patients who may have otherwise been deemed inoperable or had unsatisfactory surgical outcomes.

The technique of laparoscopic and robotic extended cholecystectomy for gallbladder cancer

The application of minimally invasive surgery for gallbladder cancer (GBC) is yet controversial. This article discusses the techniques of laparoscopic and robotic extended cholecystectomy. A 69-year-old male diagnosed with cT1-2N0 GBC underwent laparoscopic surgery, and a 55-year-old male with cT2N1 GBC underwent robotic surgery after preoperative chemotherapy. Nonanatomical partial hepatectomy with lymphadenectomy was performed. Liver parenchymal dissection was performed using Cavitron Ultrasonic Surgical Aspirator laparoscopically and Maryland bipolar dissector and Harmonic scalpel robotically. The operation time was 180 and 220 minutes, and the estimated blood loss was 140 and 130 mL, respectively. The final pathologies were pT1bN0 and pT2aN1, for which patients received adjuvant chemotherapy. There was no evidence of recurrence at 33 and 18 months without complications. Both laparoscopic and robotic extended cholecystectomy can be safely performed with the robotic surgical system as an effective alternative for GBC requiring liver resection with radical lymphadenectomy.

The Use of Cavitron Ultrasonic Surgical Aspirator for High-Risk Neuroblastoma with Image-Defined Risk Factors in Children.

Aim of the study: The cavitron ultrasonic surgical aspirator (CUSA) has gained popularity in adult surgical oncology, but its application in children is limited to liver surgery and neurosurgical procedures. The complete resection of neuroblastoma with image-defined risk factors (IDRFs) is still considered one of the most difficult procedures to achieve in pediatric surgical oncology, with a high morbidity rate and potential risk of intraoperative mortality. The aim of our study is to describe the application of ultrasonic dissection in neuroblastoma with IDRFs. Methods: A retrospective study was performed, analyzing patients operated on from 2000 to 2018. Patient characteristics, resection completeness, and postoperative surgical and oncology outcomes were analyzed. Main results: Twenty-six patients with high-risk neuroblastoma and IDRFs were operated on in the study period with a CUSA. A complete macroscopic resection was performed in 50% of patients, while the other half was operated on with minimal residual (<5 mL). Six post-operative complications occurred without the need for surgery (Clavien−Dindo < 3). The overall survival was 50%, with a median follow-up of 69.6 months (5.6−140.4). Conclusions: The application of the CUSA in neuroblastoma with IDRFs can be considered an effective and safe alternative technique to achieve a radical resection.

Application of cavitron ultrasonic surgical aspirator (CUSA) in orbital surgeries

Application of cavitron ultrasonic surgical aspirator (CUSA) in orbital surgeries - IJCEO- Print ISSN No: - 2395-1443 Online ISSN No:- 2395-1451 Article DOI No:- 10.18231/j.ijceo.2022.091, Indian Journal of Clinical and Experimental Ophthalmology-Indian J Clin Exp Ophthalmol

PO44 Presentation Time: 4:45 PM: HDR Intracavitary Brachytherapy in the Management of Recurrent VaIN3: A Case Report and Review of the Literature

<h3>Purpose</h3> Vaginal intraepithelial neoplasia, or VaIN, is a pre-cancerous condition in the cell of the vagina. It has an estimated occurrence of 0.2-0.3 cases per 100,000 women in the U.S. It is classified into three groups based on histologic characteristics: low-grade (VaIN 1), intermediate-grade (VaIN 2), and high-grade (Vain 3). High-grade lesions includes vaginal carcinoma-in-situ and are known as a pre-malignant lesion most likely to progress to vaginal cancer. Risk factors include HPV, cigarette smoking and immunodeficiency. VaIN 1 are usually treated with close observation; VaIN 2 and 3 usually require prompt treatments including excision (wide local excision, partial or total vaginectomy), ablation (CO2 laser, ultrasonic surgical aspiration), topical therapy (imiquimod, fluorouracil), and radiation therapy. Yet no standard treatment exists. Given that it is a rare pre-malignant condition, there have been limited reports on the use of intracavitary brachytherapy. Proper dose prescription remains challenging, especially for patients with history of hysterectomy. <h3>Materials and methods</h3> We report a case of a 70 year-old female with history of hysterectomy 15 years ago for endometriosis and recurrent diffuse VaIN3 that was refractory to multiple lines of local therapy who received HDR cylinder brachytherapy. The report includes clinical and diagnostic studies, dosimetric considerations in treatment planning for improved target coverage, and a review of the limited existing literature of HDR brachytherapy for VaIN3. <h3>Results</h3> HDR, MDR and LDR had all been utilized to treat VaIN with comparable tumor control and toxicity. Reported acute side effects include vaginitis, urethritis, and proctitis; whereas late side effects include vaginal atrophy/fibrosis/telangiectasia/stenosis. What made this case especially challenging is her past surgical history of hysterectomy. The vaginal vault is difficult to assess after hysterectomy with potential abnormal cells sequestered above the suture line, and is thus prone to underdosing. Therefore some institutions prefer to use ovoids rather than cylinder to adequately cover the upper vagina; whereas others argue that cylinder is better for treating extensive lesions by providing a uniform coverage of the entire vagina despite higher toxicity. Upper vagina is also noted to tolerate a higher radiation dose compared to lower vagina. Doses are often prescribed to different depths based on location in the vagina, or on doses to the OARs. Our patient was treated with a dose of 30Gy in 5 fractions given twice weekly, prescribed to 3mm depth for the proximal 3cm vagina and to surface for the remaining 5cm vagina. She had complete clinical response and was encouraged to continue vaginal dilator use to prevent vaginal stenosis and regular follow-ups with pelvic exams. <h3>Conclusions</h3> HDR brachytherapy is a feasible and effective alternative approach to treat patients who are non-surgical candidates, have recurrent disease or disease refractory to previous treatments, or have extensive multifocal VaIN. Our case would be a valuable addition to the existing limited literature regarding the treatment efficacy and proper dose prescription for this rare condition.

Endoscopic mitral valve repair utilizing cavitron ultrasonic surgical aspirator for active endocarditis.

Mitral valve repair for endocarditis in an acute setting is still challenging due to difficulties in debriding friable tissue and in leaving enough non-infected tissue for reconstruction. Endoscopic approaches for complex mitral valve procedures via a minimally invasive approach have been reported from high-volume programs. However, the role of endoscopic mitral valve surgery for acute infective endocarditis has not been clearly defined. We report our technique of endoscopic mitral valve repair using the cavitron ultrasonic surgical aspirator system for active endocarditis. The cavitron ultrasonic surgical aspirator with a low power setting provides enough debridement of the infective tissue and leaves healthy tissue adequate for repair under a totally endoscopic vision.

Total robotic right hepatectomy for multifocal hepatocellular carcinoma using vessel sealer.

Rapid adoption of a robotic approach as a minimally invasive surgery tool has enabled surgeons to perform more complex hepatobiliary surgeries than conventional laparoscopic surgery. Although various types of liver resections have been performed robotically, parenchymal transection is challenging as commonly used instruments (Cavitron Ultrasonic Surgical Aspirator [CUSA] and Harmonic) lack articulation. Further, CUSA also requires a patient-side assistant surgeon with hepatobiliary laparoscopic skills. We present a case report of total robotic right hepatectomy for multifocal hepatocellular carcinoma in a 70-year-old male using 'Vessel Sealer' for parenchymal transection. Total operative time was 520 minutes with a blood loss of ~400 mL. There was no technical difficulty or instrument failure encountered during surgery. The patient was discharged on postoperative day five without any significant complications such as bile leak. Thus, Vessel Sealer, a fully articulating instrument intended to seal vessels and tissues up to 7 mm, can be a promising tool for parenchymal transection in a robotic surgery.